Company Data

Ocugen, Inc.

Fundamental Analysis:

Ocugen, Inc.

Ocugen, Inc.
Fundamental Analysis:
Current Price
$1.4264 -6.16%
Market Cap
Price Target
Refer to Report
52wk Range
$0.345 - $2.105
Advanced Market Data


Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patient’s lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy